Literature DB >> 16112418

Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells.

Sang-Ho Choi1, Eunok Im, Hyun Kyung Kang, Ji-Hyeon Lee, Hi-Suk Kwak, Young-Tae Bae, Hee-Juhn Park, Nam Deuk Kim.   

Abstract

Costunolide, a natural sesquiterpene compound, has been known having cytotoxic and chemopreventive effects on various human cancer cells. In the present study, we examined the effects of costunolide on telomerase activity and on the components of telomerase in MCF-7 (wild-type p53) and MDA-MB-231 (mutant p53) cells. We found that costunolide inhibited the growth and telomerase activity of MCF-7 and MDA-MB-231 cells in a concentration- and time-dependent manner. The expression of hTERT mRNA was also inhibited but hTR mRNA was not. In addition, the bindings of transcription factors in hTERT promoters were significantly decreased in both cells by the treatment of costunolide. These results suggest that costunolide inhibited the growth of both MCF-7 and MDA-MB-231 cells and this effect was mediated at least in part by a significant reduction in telomerase activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16112418     DOI: 10.1016/j.canlet.2005.01.011

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  13 in total

1.  Cisplatin's tumoricidal effect on human breast carcinoma MCF-7 cells was not attenuated by American ginseng.

Authors:  Han H Aung; Sangeeta R Mehendale; Chong Zhi Wang; Jing-Tian Xie; Eryn McEntee; Chun-Su Yuan
Journal:  Cancer Chemother Pharmacol       Date:  2006-06-24       Impact factor: 3.333

2.  Targeted Covalent Inhibition of Telomerase.

Authors:  Rick C Betori; Yue Liu; Rama K Mishra; Scott B Cohen; Stephen J Kron; Karl A Scheidt
Journal:  ACS Chem Biol       Date:  2020-02-24       Impact factor: 5.100

3.  Crocin from Crocus sativus possesses significant anti-proliferation effects on human colorectal cancer cells.

Authors:  H H Aung; C Z Wang; M Ni; A Fishbein; S R Mehendale; J T Xie; C Y Shoyama; C S Yuan
Journal:  Exp Oncol       Date:  2007-09

4.  Costunolide induces G1/S phase arrest and activates mitochondrial-mediated apoptotic pathways in SK-MES 1 human lung squamous carcinoma cells.

Authors:  Peiyan Hua; Guangxin Zhang; Yifan Zhang; Mei Sun; Ranji Cui; Xin Li; Bingjin Li; Xingyi Zhang
Journal:  Oncol Lett       Date:  2016-03-01       Impact factor: 2.967

5.  Sesquiterpene lactones downregulate G2/M cell cycle regulator proteins and affect the invasive potential of human soft tissue sarcoma cells.

Authors:  Birgit Lohberger; Beate Rinner; Nicole Stuendl; Heike Kaltenegger; Bibiane Steinecker-Frohnwieser; Eva Bernhart; Ehsan Bonyadi Rad; Annelie Martina Weinberg; Andreas Leithner; Rudolf Bauer; Nadine Kretschmer
Journal:  PLoS One       Date:  2013-06-14       Impact factor: 3.240

6.  Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle.

Authors:  Suwit Duangmano; Sumana Dakeng; Weena Jiratchariyakul; Apichart Suksamrarn; Duncan R Smith; Pimpicha Patmasiriwat
Journal:  Int J Mol Sci       Date:  2010-12-22       Impact factor: 5.923

Review 7.  Potential anti-cancer activities and mechanisms of costunolide and dehydrocostuslactone.

Authors:  Xuejing Lin; Zhangxiao Peng; Changqing Su
Journal:  Int J Mol Sci       Date:  2015-05-13       Impact factor: 5.923

Review 8.  Telomerase Inhibitors from Natural Products and Their Anticancer Potential.

Authors:  Kumar Ganesan; Baojun Xu
Journal:  Int J Mol Sci       Date:  2017-12-21       Impact factor: 5.923

9.  Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway.

Authors:  Zhangxiao Peng; Yan Wang; Jianhui Fan; Xuejing Lin; Chunying Liu; Yang Xu; Weidan Ji; Chao Yan; Changqing Su
Journal:  Sci Rep       Date:  2017-01-24       Impact factor: 4.379

10.  Nrf2-driven TERT regulates pentose phosphate pathway in glioblastoma.

Authors:  F Ahmad; D Dixit; V Sharma; A Kumar; S D Joshi; C Sarkar; E Sen
Journal:  Cell Death Dis       Date:  2016-05-05       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.